4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-21-005218
Chief Technology Officer bought 700 shares at $3.16 ($2,212)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shultz Randall Chief Technology Officer | 2020-08-03 | Purchase | +700 | $3.16 | $2,212 | 13,000 | D |
| Derivatives | |||||||
| Shultz Randall Chief Technology Officer | 2021-01-21 | Grant or award · Stock Option (right to buy) | +55,000 | 115,000 | D | ||
| Open-market purchases · 700 sh · avg $3.16 · $2,212 | |||||||
Loading xslF345X03/doc4.xml…